David James Lennon, CHIEF EXECUTIVE OFFICER at Aadi Bioscience, Inc. (AADI), sold 5,690 shares at $2.35 ($13K) on 2025-03-03, disclosed to the SEC on 2025-03-03.
Open-market sale of $13k AADI by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| WHWK | SELL | 2026-04-03 | $93K | — | Filing → |
| WHWK | SELL | 2026-03-10 | $17K | — | Filing → |
| AADI | SELL | 2024-10-03 | $19K | — | Filing → |